JAMA Internal Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2024-10-31 ms6000001999902226 来自广东省

审稿速度:1.0
经验分享：很好中，连续三篇

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2022-09-22 1ding&accept

偏重的研究方向：内科学
经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了

302 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2021-12-28 MS68862005

讨论中第一段一定要撰写文章的总括么？

519 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2021-12-28 小动量

模式图一般放在讨论中展示还是放在结果部分？

697 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2019-02-14 122af8bam19(暂无昵称)

请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表::
请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表:
请问多久会收到通知

139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知

841 0

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2018-08-10 1ddccb01m45(暂无匿称)

请问多久会收到通知150****5932 2017-03-24 06:23:00 发表:
今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊

150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊

1084 0

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2017-07-16 gu_8183

谁能预测明年会有多少分?

988 0

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2017-03-24 150144db3am

审稿速度:2.0 | 投稿命中率:25.0
经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊

1075 0

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2015-08-27 lock

三天就拒稿了，好牛

1019 0

[GetPortalCommentsPageByObjectIdResponse(id=2234263, encodeId=24be2234263c7, content=审稿速度:1.0 经验分享：很好中，连续三篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Thu Oct 31 11:23:32 CST 2024, time=2024-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089823, encodeId=14ff2089823fa, content=偏重的研究方向：内科学 经验分享：两天巨稿，然后给转投到jama network open了，还在in quality control阶段，2天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7aa6493786, createdName=1ding&accept, createdTime=Thu Sep 22 20:06:04 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087395, encodeId=2f94108e395dd, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087396, encodeId=8588108e396af, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=697, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566745, encodeId=6a09566e4520, content=请问这本杂志接不接收原始研究的letter？？？ 139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知139****0345(暂无匿称) 2018-08-10 00:00:00 发表: 请问多久会收到通知, beContent=139****0345(暂无匿称) 2018-08-10 发表:: 请问多久会收到通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e22351105, createdName=122af8bam19(暂无昵称), createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559993, encodeId=4f4255999376, content=请问多久会收到通知150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=150****5932 2017-03-24 06:23:00 发表: 今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1084, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Fri Aug 10 00:00:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544463, encodeId=ced2544463e9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=988, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534622, encodeId=029c534622ac, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今天早上收到 JAMA INTERNAL MEDICINE杂志发来的接受信，非常激动。我是根据之前发表的一篇Article写的一个letter，只能有3个作者。现在发现一个问题，这篇文章当时投稿时有第一作者和通讯作者，现在第一作者就是通讯作者，不知道是否可以咨询杂志社能否更改，还是只能这样了？这样做是否危险，请各位大侠指导啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=185224604, createdName=150144db3am, createdTime=Fri Mar 24 06:23:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514861, encodeId=57795148617a, content=三天就拒稿了，好牛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1019, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=624d1638652, createdName=lock, createdTime=Thu Aug 27 20:45:00 CST 2015, time=2015-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509623, encodeId=54c6509623fc, content=内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Sat Feb 07 05:37:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]

2015-02-07 mileo

内部的academic editor先把关，觉得不行或者没什么兴趣的直接就拒了牛的很。。也没说什么意见，就说杂志是high quality的意思是说我们的研究不够资格。。

1184 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务